Therefore, DDX5 or DDX17 is involved in the progression of various cancers (glioma, colon cancer, glioblastoma, colon adenocarcinoma, adult T-cell leukemia/lymphoma) by participating in the NF-κB signaling pathway (Figure 5i). This evidence concerns the gene DDX17 and central nervous system cancer.